1,2-Dichloroethane → HCID 23657985, compound
Reaction equation
[Cl:1][C:2]1[C:10]2[NH:9]N=C[C:6]=2[C:5]2[CH2:11][N:12]([CH2:21][C:22]([CH3:25])([CH3:24])[CH3:23])[C:13](=[O:20])[C@H:14]([CH2:16][C:17]([OH:19])=O)[CH2:15][C:4]=2[CH:3]=1.[NH:26]1[CH2:31][CH2:30][CH:29]([C:32]2[C:37](=[O:38])[NH:36][C:35]3[CH:39]=[CH:40][S:41][C:34]=3[CH:33]=2)[CH2:28][CH2:27]1.[CH:42]1C=CC2N(O)N=NC=2[CH:47]=1.C(Cl)CCl.CCN(C(C)C)C(C)C>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[C:4]2[CH2:15][C@@H:14]([CH2:16][C:17]([N:26]3[CH2:27][CH2:28][CH:29]([C:32]4[C:37](=[O:38])[NH:36][C:35]5[CH:39]=[CH:40][S:41][C:34]=5[CH:33]=4)[CH2:30][CH2:31]3)=[O:19])[C:13](=[O:20])[N:12]([CH2:21][C:22]([CH3:25])([CH3:23])[CH3:24])[CH2:11][C:5]2=[C:6]2[C:10]=1[NH:9][CH:47]=[CH:42]2Participants
Procedure
To a solution of (S)-2-(4-chloro-9-neopentyl-8-oxo-3,6,7,8,9,10-hexahydroazepino [3,4-e]indazol-7-yl)acetic acid (123 mg, 0.338 mmol), 6-(piperidin-4-yl)thieno[3,2-b]pyridin-5(4H)-one (79 mg, 0.338 mmol), HOBT (56.9 mg, 0.372 mmol), EDC (71.3 mg, 0.372 mmol) in DMF (5 mL) was added DIEA (0.295 mL, 1.690 mmol) at rt, and the mixture was stirred over night. Partial of the solvent was removed under N2 at 60° C., and the residue was purified on reverse phase PrepHPLC to afford the expected product, (S)-6-(1-(2-(7-chloro-2-neopentyl-3-oxo-1,2,3,4,5,8-hexahydroazepino [3,4-e]indol-4-yl)acetyl)piperidin-4-yl)thieno[3,2-b]pyridin-5(4H)-one (113 mg, 57.6%) as a white solid. 1H-NMR (400 MHz, CHLOROFORM-D) δ ppm 0.80 (d, J=6.80 Hz, 11 H) 1.52 (ddd, J=12.46, 8.06, 4.41 Hz, 1H) 1.87-1.96 (m, 1H) 2.00 (s, 1H) 2.38-2.49 (m, 1H) 2.75 (td, J=12.84, 2.01 Hz, 1H) 2.94-3.04 (m, 1H) 3.07-3.18 (m, 4 H) 3.66 (dd, J=13.60, 2.77 Hz, 1H) 3.96-4.06 (m, 1H) 4.23 (s, 1H) 4.61-4.72 (m, 2H) 5.51 (d, J=17.37 Hz, 1H) 7.04 (dd, J=5.29, 2.01 Hz, 1H) 7.22 (s, 1H) 7.70 (dd, J=5.41, 2.14 Hz, 1H) 7.89 (d, J=18.38 Hz, 1H) 8.24 (s, 1H); Mass spec. 580.25 (MH+), Calc. for C30H34ClN5O3S 579.21.
Workup
- customPartial of the solvent was removed under N2 at 60° C.
- customthe residue was purified on reverse phase PrepHPLC
Sources & evidence
- ORD record
- ord-1f425a7d5ef54642b44b3026ea0cdc8e
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07470680B2
Reaction notes
Loading…